Drug hypersensitivity: pharmacogenetics and clinical syndromes. - Wikidata - awgldk - TriplyDB

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

http://www.wikidata.org/entity/Q34701492

about

Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity Idiosyncratic adverse drug reactions: current concepts Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions Stevens-johnson syndrome associated with drugs and vaccines in children: a case-control study Pharmacogenomics of off-target adverse drug reactions.Japan PGx Data Science Consortium Database: SNPs and HLA genotype data from 2994 Japanese healthy individuals for pharmacogenomics studies.Stevens-Johnson Syndrome following Failure of Genetic Screening prior to Carbamazepine Prescription.Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management.PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.From the nephrologist's point of view: diversity of causes and clinical features of acute kidney injury Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis Testing for drug hypersensitivity syndromes.HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand.Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.Negative regulation by PD-L1 during drug-specific priming of IL-22-secreting T cells and the influence of PD-1 on effector T cell function.Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America.Pharmacogenomics and adverse drug reactions in children.Educational case series: Mechanisms of drug allergy.HLA alleles and drug hypersensitivity reactions.Eosinophilic disorders in various diseases.The structural basis of HLA-associated drug hypersensitivity syndromes.HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review.Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.Skin toxicity of targeted cancer agents: mechanisms and intervention.HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury.Toxocarosis and putative DRESS syndrome in an oncological patient: a case report.Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis.The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications.In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper.Mechanisms involved in the Abacavir-mediated hypersensitivity syndrome.Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations.[Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a review].HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis.

P2860

Q26784638-93B57F37-D221-41F1-ADB0-7005627E931E Q26800973-699D2EF2-E142-407C-B771-6CEFACE7F051 Q26824391-7CBDC3A9-0C37-4B68-AD2D-E315C470D09B Q26853305-955C7E74-A42E-48EE-968C-D48EEA82909D Q28066096-CC4938ED-560A-4516-B693-C5C8B449619B Q28534684-8E9B10F0-DB7B-4707-AB8B-658D1C9D515E Q30400366-F232FACF-D2A7-4F5F-B213-30FDC8886AFC Q30927447-B84E4BA1-2EC4-45C4-A7A2-F7E223489464 Q33572210-260598B7-B90B-47A5-B679-6494694492E1 Q33838853-162688F0-D2B4-4078-8B00-0782AAB1D1B1 Q34225850-762FD9AB-3971-46C7-AAA4-7EEFB7BD9331 Q35023687-D6DCC2D6-CB60-4245-890D-08C5A0BD7372 Q35094201-66437F92-E71A-449F-8C8D-092BE3811321 Q35168561-5D3A0795-6E97-4BB1-BC71-F0D99E9D4027 Q35891577-CED4EBF2-E5F8-413F-A480-6BE66F63EBEF Q35996671-A3F6682D-6BD0-4E10-950E-01302BF86656 Q36766056-5A4B3001-F213-4C8A-BF25-19055062AD7D Q37100410-DB0F6253-3702-4A83-AE53-0476E64DE9C3 Q37590883-AD2F5434-F597-48AD-B1B9-221FE14E7FE3 Q37633276-B9B57BF0-ABAC-433C-8C67-0B32FACE4BE8 Q37695437-6F1F5D33-434B-48C6-9B0B-E63F15D10D38 Q37719025-890B88AE-B6B9-4D92-BDFA-4196A60609B9 Q37885432-C0D6C9ED-56BB-46FE-BDCC-F0C1DCBB93E2 Q37963995-8674A5D1-4FE6-4EBD-BD4F-07AF621141D8 Q37967448-C0631BD4-D5F9-428A-8F43-4B64ECC8F04F Q38050483-E8CE0064-2A69-4A12-A543-7054B20203CC Q38058271-8CB80B1D-1573-4587-8CAF-650513FB1F96 Q38123116-65D3B24C-8D8D-4E23-88A3-AF3DC98F0608 Q38125504-F94CF01F-E6E0-4F80-BAD7-5E7B2BC2B51C Q38131961-CCDBE5B4-D09F-4902-BF6B-C379C6E29456 Q38260985-3EF1E03E-0692-48F9-B25C-A7D33B1B0456 Q38419347-1DB5855C-8802-47ED-9999-928297FE1C6E Q38600529-D44F2A30-853A-4DEC-A623-E453D0403D01 Q39422837-A148C773-DFA8-4613-A4B8-8440988ABC9A Q39679666-21005386-6714-4124-969B-2F665523CEFC Q39909074-C1BCE168-D2F6-406A-B2E6-852F066425FD Q42392300-9F610738-51F2-4DE9-BB37-1142445565AA Q44842257-8EE27100-1306-420C-922C-B855F0CF13AD Q46313259-E72D70DA-123F-4DFB-8E53-41ED18215DD0 Q46859144-2FDF8F07-387C-40F5-A8EB-A369DE246ECA

P2860

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

http://www.wikidata.org/entity/Q34701492

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

@ast

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

@en

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

@nl

type

label

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

@ast

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

@en

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

@nl

prefLabel

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

@ast

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

@en

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

@nl

P1433

Q34701492-D69C5582-C590-4F03-87FB-D5296FFDBA05

P1476

Q34701492-90F7ECE6-7B7B-4A8D-A224-FDCF36E09804

P2093

Q34701492-076328F6-F2ED-42B3-87B6-FE199ACE8373

Q34701492-6E262DAE-8A82-459C-B344-926804A904CB

Q34701492-C341F447-989B-46CA-9B94-D9747061EDD9

Q34701492-E5425576-BF79-4B8A-A9C6-774963F221D9

P2860

Q34701492-0194EB01-CBBB-4CF6-9FAB-61006A17D017

Q34701492-07258560-514D-4F9E-8066-230B155F3ABF

Q34701492-082DEB0E-D400-405E-B842-B4011C372F09

Q34701492-0B174CF1-5ECD-4EEF-8F09-37F9183D8E82

Q34701492-0F2088AA-A83C-4FFA-AC9A-F97E635CB5B7

Q34701492-1A359835-08CF-48C7-BB65-90A8FD8AE5ED

Q34701492-214F7760-7138-4A59-BDF0-19D953F7B61C

Q34701492-2461E019-48C3-4CDA-B1C3-24057B0CD38D

Q34701492-256BEB28-5023-4A92-9FE7-E4ED7F7AC884

Q34701492-2742740C-D59F-4DBE-88D7-445970FA4DE0

P304

Q34701492-C63975A3-3E1C-4287-B4E7-6FC843B9FC77

P31

Q34701492-16411E01-5A2B-4818-9E61-16B55E9AB3EF

P356

Q34701492-2B815BBE-F4D7-43CA-8E2C-A683C56EC833

P407

Q34701492-DB143609-73B3-4E04-BDC3-5895786085F1

P433

Q34701492-5EE19169-8841-48F4-955A-FBF3C0DD31CE

P478

Q34701492-5756A488-0043-493E-8036-0F51418D132F

P50

Q34701492-1BE73385-8D19-479A-A3F4-FF44C25D3271

P577

Q34701492-FC948D04-A5D0-41BE-A792-86D8DE286813

P5875

Q34701492-9CC68692-493F-4E73-B071-47D13057FDCE

P698

Q34701492-04C0C02F-A746-4A9B-8EEC-5B1E729AEEEE

P932

Q34701492-9D32BD59-195C-4F2F-9808-C0AEE92A1BD9

P356

J.JACI.2010.11.046

P1433

The Journal of Allergy and Clinical Immunology

P1476

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

@en

P2093

Jean-Claude Roujeau

http://www.w3.org/2001/XMLSchema#string

Maja Mockenhaupt

http://www.w3.org/2001/XMLSchema#string

Simon A Mallal

http://www.w3.org/2001/XMLSchema#string

Wen-Hung Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

Timing of new black box warnings and withdrawals for prescription medications

Medical genetics: a marker for Stevens-Johnson syndrome

Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

Pharmacogenetics of drug hypersensitivity.

Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern.

P304

S60-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2010.11.046

http://www.w3.org/2001/XMLSchema#string

P407

P433

3 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth J. Phillips

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50264846

http://www.w3.org/2001/XMLSchema#string

P698

21354501

http://www.w3.org/2001/XMLSchema#string

P932

3061439

http://www.w3.org/2001/XMLSchema#string